Clinical Experience in the Administration of Intravitreal Injection Therapy at a Tertiary University Hospital in Jordan During the COVID-19 Lockdown
Omar A Saleh,1 Hisham Jammal,1 Noor Alqudah,1 Asem Alqudah,1 Nakhleh Abu-Yaghi2 1Department of Ophthalmology, Jordan University of Science and Technology, Irbid, Jordan; 2Department of Special Surgery/Ophthalmology Division, School of Medicine, The University of Jordan, Amman, JordanCorrespondence:...
Guardado en:
Autores principales: | Saleh OA, Jammal H, Alqudah N, Alqudah A, Abu-Yaghi N |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7627f8317c83494aa2dd32de90345447 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor
por: Elfalah M, et al.
Publicado: (2021) -
Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
por: Fouda SM, et al.
Publicado: (2017) -
Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion
por: Hall J
Publicado: (2016) -
The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions
por: Ivanovska Adjievska B, et al.
Publicado: (2017) -
Effect of prophylactic timolol 0.1% gel on intraocular pressure after an intravitreal injection of ranibizumab: a randomized study
por: Pece A, et al.
Publicado: (2016)